These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
657 related articles for article (PubMed ID: 30659097)
21. Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Zhang T; Zhang J; You X; Liu Q; Du Y; Gao Y; Shan C; Kong G; Wang Y; Yang X; Ye L; Zhang X Hepatology; 2012 Dec; 56(6):2051-9. PubMed ID: 22707013 [TBL] [Abstract][Full Text] [Related]
22. SHP2 is induced by the HBx-NF-κB pathway and contributes to fibrosis during human early hepatocellular carcinoma development. Kang HJ; Chung DH; Sung CO; Yoo SH; Yu E; Kim N; Lee SH; Song JY; Kim CJ; Choi J Oncotarget; 2017 Apr; 8(16):27263-27276. PubMed ID: 28460481 [TBL] [Abstract][Full Text] [Related]
23. Hepatitis B virus induces hypoxia-inducible factor-2α expression through hepatitis B virus X protein. Hu JL; Liu LP; Yang SL; Fang X; Wen L; Ren QG; Yu C Oncol Rep; 2016 Mar; 35(3):1443-8. PubMed ID: 26647960 [TBL] [Abstract][Full Text] [Related]
24. Role of microRNA-210-3p in hepatitis B virus-related hepatocellular carcinoma. Morishita A; Fujita K; Iwama H; Chiyo T; Fujihara S; Oura K; Tadokoro T; Mimura S; Nomura T; Tani J; Yoneyama H; Kobayashi K; Kamada H; Guan Y; Nishiyama A; Okano K; Suzuki Y; Himoto T; Shimotohno K; Masaki T Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G401-G409. PubMed ID: 31905024 [TBL] [Abstract][Full Text] [Related]
25. Hepatitis B virus X protein upregulates alpha-fetoprotein to promote hepatocellular carcinoma by targeting miR-1236 and miR-329. Zhang C; Liu P; Zhang C J Cell Biochem; 2020 Mar; 121(3):2489-2499. PubMed ID: 31680299 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of microRNA-15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2-induced Globo H expression. Wu CS; Yen CJ; Chou RH; Chen JN; Huang WC; Wu CY; Yu YL Int J Cancer; 2014 Apr; 134(7):1638-47. PubMed ID: 24122375 [TBL] [Abstract][Full Text] [Related]
27. MiR-19a, miR-122 and miR-223 are differentially regulated by hepatitis B virus X protein and involve in cell proliferation in hepatoma cells. Yu G; Chen X; Chen S; Ye W; Hou K; Liang M J Transl Med; 2016 May; 14(1):122. PubMed ID: 27150195 [TBL] [Abstract][Full Text] [Related]
28. Interaction of the hepatitis B virus X protein with the lysine methyltransferase SET and MYND domain-containing 3 induces activator protein 1 activation. Hayashi M; Deng L; Chen M; Gan X; Shinozaki K; Shoji I; Hotta H Microbiol Immunol; 2016 Jan; 60(1):17-25. PubMed ID: 26616333 [TBL] [Abstract][Full Text] [Related]
29. Suppression of Hepatocyte Nuclear Factor 4 α by Long-term Infection of Hepatitis B Virus Contributes to Tumor Cell Proliferation. Park S; Ha YN; Dezhbord M; Lee AR; Park ES; Park YK; Won J; Kim NY; Choo SY; Shin JJ; Ahn CH; Kim KH Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32023898 [TBL] [Abstract][Full Text] [Related]
30. HBx protein-induced upregulation of microRNA-221 promotes aberrant proliferation in HBV‑related hepatocellular carcinoma by targeting estrogen receptor-α. Chen JJ; Tang YS; Huang SF; Ai JG; Wang HX; Zhang LP Oncol Rep; 2015 Feb; 33(2):792-8. PubMed ID: 25483016 [TBL] [Abstract][Full Text] [Related]
31. Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis. Pang R; Lee TK; Poon RT; Fan ST; Wong KB; Kwong YL; Tse E Gastroenterology; 2007 Mar; 132(3):1088-103. PubMed ID: 17383430 [TBL] [Abstract][Full Text] [Related]
32. SPG21, a potential oncogene targeted by miR-128-3p, amplifies HBx-induced carcinogenesis and chemoresistance via activation of TRPM7-mediated JNK pathway in hepatocellular carcinoma. Zhou P; Yao W; Liu L; Yan Q; Chen X; Wei X; Ding S; Lv Z; Zhu F Cell Oncol (Dordr); 2024 Oct; 47(5):1757-1778. PubMed ID: 38753154 [TBL] [Abstract][Full Text] [Related]
33. Hepatitis B virus X protein inhibits tumor suppressor miR-205 through inducing hypermethylation of miR-205 promoter to enhance carcinogenesis. Zhang T; Zhang J; Cui M; Liu F; You X; Du Y; Gao Y; Zhang S; Lu Z; Ye L; Zhang X Neoplasia; 2013 Nov; 15(11):1282-91. PubMed ID: 24339740 [TBL] [Abstract][Full Text] [Related]
34. Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Yan Y; Huang P; Mao K; He C; Xu Q; Zhang M; Liu H; Zhou Z; Zhou Q; Zhou Q; Ou B; Liu Q; Lin J; Chen R; Wang J; Zhang J; Xiao Z Oncogene; 2021 Jan; 40(1):28-45. PubMed ID: 33051595 [TBL] [Abstract][Full Text] [Related]
35. Long non-coding RNA HULC activates HBV by modulating HBx/STAT3/miR-539/APOBEC3B signaling in HBV-related hepatocellular carcinoma. Liu Y; Feng J; Sun M; Yang G; Yuan H; Wang Y; Bu Y; Zhao M; Zhang S; Zhang X Cancer Lett; 2019 Jul; 454():158-170. PubMed ID: 30981758 [TBL] [Abstract][Full Text] [Related]
37. Hepatitis B virus X protein promotes vimentin expression via LIM and SH3 domain protein 1 to facilitate epithelial-mesenchymal transition and hepatocarcinogenesis. You H; Yuan D; Bi Y; Zhang N; Li Q; Tu T; Wei X; Lian Q; Yu T; Kong D; Yang X; Liu X; Liu X; Kong F; Zheng K; Tang R Cell Commun Signal; 2021 Mar; 19(1):33. PubMed ID: 33722250 [TBL] [Abstract][Full Text] [Related]
38. Interleukin-34 mediated by hepatitis B virus X protein via CCAAT/enhancer-binding protein α contributes to the proliferation and migration of hepatoma cells. Kong F; Zhou K; Zhu T; Lian Q; Tao Y; Li N; Tu T; Bi Y; Yang X; Pan X; Li S; You H; Zheng K; Tang R Cell Prolif; 2019 Nov; 52(6):e12703. PubMed ID: 31621133 [TBL] [Abstract][Full Text] [Related]
39. Truncated HBx-dependent silencing of GAS2 promotes hepatocarcinogenesis through deregulation of cell cycle, senescence and p53-mediated apoptosis. Zhu R; Mok MT; Kang W; Lau SS; Yip WK; Chen Y; Lai PB; Wong VW; To KF; Sung JJ; Cheng AS; Chan HL J Pathol; 2015 Sep; 237(1):38-49. PubMed ID: 25925944 [TBL] [Abstract][Full Text] [Related]
40. Oncogenic circuit constituted by Ser31-HBx and Akt increases risks of chronic hepatitis and hepatocellular carcinoma. Lee WP; Lan KH; Li CP; Chao Y; Lin HC; Lee SD Biochim Biophys Acta; 2016 Apr; 1862(4):837-849. PubMed ID: 26791804 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]